These novel therapies, including Semaglutide , a similar compound, and Zaxig , represent a significant advancement in addressing type 2 hyperglycemia and promoting weight reduction . They work by mimicking the body’s natural hormone GLP-1 , helping to moderate blood sugar and decrease hunger . The therapy has slightly different characteristics an